U.S. stocks opened lower, with the Dow Jones Industrial Average down 0.1%, the S&P 500 up 0.13%, and the Nasdaq Composite up 0.3%. Biopharmaceutical company uniQure (QURE.O) fell 39% after its 48-month data on its Huntington's disease gene therapy fa

2026-09-29

U.S. stocks opened lower, with the Dow Jones Industrial Average down 0.1%, the S&P 500 up 0.13%, and the Nasdaq Composite up 0.3%. Biopharmaceutical company uniQure (QURE.O) fell 39% after its 48-month data on its Huntington's disease gene therapy failed to reach statistical significance. Summit Therapeutics (SMMT.O) rose 19.2% after AstraZeneca announced a $2 billion investment to collaborate on developing cancer drugs.